Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05186272 · ClinicalTrials.gov registry record · Phase 3
mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression
A Phase 3 study of Postpartum Depression and Perinatal Depression, sponsored by Kaiser Permanente.
- Active
- Registry status
- Phase 3
- Development phase
- 600
- Enrollment target
- 1
- Study location
NCT05186272: Active Phase 3 study of Postpartum Depression and Perinatal Depression, sponsored by Kaiser Permanente.
NCT05186272 is a Phase 3 study of Postpartum Depression and Perinatal Depression that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 600 participants, above the 463-participant average among 47 other Postpartum Depression trials with a reported enrollment target (30% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05186272, a Phase 3 study of Postpartum Depression and Perinatal Depression, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
Postpartum depression (PPD) is associated with significant health consequences for mothers and children, and the current COVID-19 pandemic has had a major impact on the mental health of particularly vulnerable populations including pregnant Black and Latina women. There is an urgent need for evidence-based, accessible, and scalable mental health care options for these high-risk, vulnerable women. This study aims to: (a) compare the effectiveness of two digitally-delivered self-paced stress reduction programs in pregnant Black and Latina women at increased risk of PPD; and (b) examine barriers and facilitators to implementation within a large healthcare system.
Primary Outcome
Depression scale; total score range of 0-27; higher scores indicate higher depression.
Conditions Studied
Interventions
- BEHAVIORAL Stress reduction program 'A'
- BEHAVIORAL Stress reduction program 'B'
Study Locations (1)
California
- Kaiser Permanente Northern California - Oakland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2022-06-14 |
| Est. Completion | 2025-12 |
| Phase | Phase 3 |
What the registry record for NCT05186272 still lists
NCT05186272 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, above the 463-participant average among 47 other Postpartum Depression trials with a reported enrollment target (30% higher).
The record links to 2 conditions, with Postpartum Depression appearing as the primary indexed condition, and to 2 interventions - of which Stress reduction program 'A' is the first listed.
NCT05186272 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05186272 about?
NCT05186272 is a clinical study titled "mHealth Mindfulness Intervention for Pregnant Black and Latina Women at Risk of Postpartum Depression". Postpartum depression (PPD) is associated with significant health consequences for mothers and children, and the current COVID-19 pandemic has had a major impact on the mental health of particularly vulnerable populations including pregnant Black and Latina women. There is an urgent need for evidenc...
What is the current status of trial NCT05186272?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 600 participants. The study started on 2022-06-14. Estimated completion is 2025-12.
What conditions does trial NCT05186272 study?
This clinical trial studies the following conditions: Postpartum Depression, Perinatal Depression.
What interventions are being tested in trial NCT05186272?
The interventions under investigation include: Stress reduction program 'A' (BEHAVIORAL), Stress reduction program 'B' (BEHAVIORAL).
Who is sponsoring clinical trial NCT05186272?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05186272 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postpartum Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05186272's enrollment target sits among peer trials
600 7th of 47 higher than 41 of 47 other Postpartum Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Postpartum Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)
COMPLETED · Phase 3
-
A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression
COMPLETED · Phase 3
-
Preventing Postpartum Depression in Immigrant Latinas
RECRUITING · NA
-
In-person vs. Virtual Delivery of a Group-based Prevention of Postpartum Depression
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Maternal Mental Health Access - MaMa
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI